Anavex Life Sciences Corp (AVXL)
9.11
+0.09
(+1.00%)
USD |
NASDAQ |
Nov 22, 16:00
9.075
-0.04
(-0.38%)
After-Hours: 20:00
Anavex Life Sciences Cash from Operations (Quarterly): -5.18M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -5.18M |
| March 31, 2024 | -11.66M |
| December 31, 2023 | -7.318M |
| September 30, 2023 | -5.849M |
| June 30, 2023 | -7.653M |
| March 31, 2023 | -8.489M |
| December 31, 2022 | -5.794M |
| September 30, 2022 | -4.044M |
| June 30, 2022 | -7.054M |
| March 31, 2022 | -9.640M |
| December 31, 2021 | -3.501M |
| September 30, 2021 | -7.675M |
| June 30, 2021 | -7.521M |
| March 31, 2021 | -7.317M |
| December 31, 2020 | -7.871M |
| September 30, 2020 | -6.255M |
| June 30, 2020 | -4.044M |
| March 31, 2020 | -5.263M |
| December 31, 2019 | -5.725M |
| September 30, 2019 | -2.534M |
| June 30, 2019 | -7.501M |
| March 31, 2019 | -4.332M |
| December 31, 2018 | -4.160M |
| September 30, 2018 | -4.053M |
| June 30, 2018 | -2.088M |
| Date | Value |
|---|---|
| March 31, 2018 | -2.821M |
| December 31, 2017 | -3.620M |
| September 30, 2017 | -2.192M |
| June 30, 2017 | -2.974M |
| March 31, 2017 | -0.6977M |
| December 31, 2016 | -3.154M |
| September 30, 2016 | -1.863M |
| June 30, 2016 | -2.224M |
| March 31, 2016 | -1.903M |
| December 31, 2015 | -3.247M |
| September 30, 2015 | -1.433M |
| June 30, 2015 | -1.430M |
| March 31, 2015 | -0.6703M |
| December 31, 2014 | -0.6931M |
| September 30, 2014 | -0.9169M |
| June 30, 2014 | -0.96M |
| March 31, 2014 | -0.3475M |
| December 31, 2013 | -0.435M |
| September 30, 2013 | -0.4845M |
| June 30, 2013 | -0.0322M |
| March 31, 2013 | -0.1293M |
| December 31, 2012 | -0.1316M |
| September 30, 2012 | -0.2519M |
| June 30, 2012 | -0.2387M |
| March 31, 2012 | -0.1142M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-11.66M
Minimum
Mar 2024
-3.501M
Maximum
Dec 2021
-6.729M
Average
-7.054M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Microbot Medical Inc | -2.759M |
| Alaunos Therapeutics Inc | -0.781M |
| SELLAS Life Sciences Group Inc | -7.806M |
| Galectin Therapeutics Inc | -8.538M |
| Oragenics Inc | -1.970M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 4.55M |
| Free Cash Flow | -30.00M |
| Free Cash Flow Per Share (Quarterly) | -0.0613 |
| Free Cash Flow Yield | -3.98% |